Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 84.44 K107.29 K185.42 K207.93 K274.97 K1.09 M 1.76 M Research & development —————— — Operating income -84.44 K-107.29 K-185.42 K-207.93 K-274.97 K-1.09 M -1.76 M Non-Operating Income, Total 0181.45 K2.08 M1.97 M1.8 M1.84 M 7.69 M Interest expense, net of interest capitalized 100 K100 K100 K100 K100 K100 K 400 K Non-Operating Income, excl. Interest Expenses -100 K81.45 K1.98 M1.87 M1.7 M1.74 M 7.29 M Unusual income/expense —————— — Pretax income -84.44 K74.17 K1.9 M1.76 M1.52 M747.72 K 5.93 M Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -84.44 K74.17 K1.9 M1.76 M1.52 M747.72 K 5.93 M Discontinued operations —————— — Net income -84.44 K74.17 K1.9 M1.76 M1.52 M747.72 K 5.93 M Dilution adjustment ——0—1.8 M1.8 M — Preferred dividends ——2.08 M—1.8 M1.8 M — Diluted net income available to common stockholders -63.9 K74.17 K-185.42 K1.76 M1.52 M747.72 K 3.84 M Basic earnings per share (Basic EPS) -0.010.010.070.130.050.03 0.28 Diluted earnings per share (Diluted EPS) -0.010.010.070.130.050.03 0.28 Average basic shares outstanding 5.83 M1.36 M6.43 M6.66 M7.27 M7.27 M — Diluted shares outstanding 5.83 M1.36 M6.43 M6.86 M7.27 M7.27 M — EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —